#Sweden #Gothenburg #Zinzino #Omega-3 #Xion International

Zinzino's Strategic Acquisition of Xion International Group

In a significant move to bolster its omega-3 production capabilities, Zinzino AB, a prominent health and wellness company based in Sweden, has successfully acquired 35% of the shares in the Andorra-based Xion International Group. This acquisition, announced on July 11, 2025, signifies a pivotal step in Zinzino’s commitment to producing high-quality nutritional supplements, particularly its flagship product, BalanceOil+, renowned for its polyphenol-rich formulation that balances omega-3 levels in the diet.

Expanding Sustainable Practices

This strategic acquisition aligns with Zinzino's mission to harness sustainable practices in its production methods. By partnering with Xion, which operates cutting-edge bioreactor technology for the cultivation of microalgae, Zinzino aims to secure a reliable and eco-friendly source of omega-3 fatty acids. Xion International has developed innovative patented methods for cultivating algae, which are essential for enhancing the nutritional profiles of Zinzino's product offerings.

According to Zinzino’s CEO Dag Bergheim Pettersen, the acquisition not only addresses the increasing global demand for omega-3 products but also reinforces the company’s dedication to sustainability. "Fish oil is a finite resource," Pettersen emphasized. "Through our collaboration with Xion, we're securing a crucial raw material supply while minimizing our environmental footprint."

A Joint Venture for Future Growth

As part of this partnership, Zinzino and Xion will collaborate to develop a joint venture named PhytoFerm, in which Zinzino will hold a 55% ownership stake. The initiative aims to further enhance the production and cultivation techniques for algae, setting a new standard for clean and sustainable production in the nutritional supplement industry.

Xion’s award-winning technology is designed to optimize algae production in a way that adheres to natural principles, thus ensuring high efficiency and sustainability. Currently, Xion's operations produce approximately EUR 1.3 million annually, supplying many existing spirulina-based products that Zinzino has incorporated since acquiring Xelliss in 2024.

With the completion of this acquisition, Zinzino is prepared to lay the groundwork for its planned expansion into new markets and product categories. The total investment for the 35% stake amounts to EUR 1.2 million, consisting of EUR 0.7 million in cash and EUR 0.5 million in newly issued Zinzino B shares.

The Future of Nutritional Solutions

The partnership with Xion is expected to pave the way for Zinzino to explore further innovations in algae technology and nutritional supplements. Pettersen highlighted the importance of investing in next-generation solutions to meet the evolving needs of health-conscious consumers. As the demand for plant-based and sustainable nutritional products continues to rise, Zinzino positions itself to be at the forefront of this trend.

Tino Bacchetta, founder of Xion, expressed optimism about the future of the joint venture. He indicated that PhytoFerm will play a crucial role in producing omega-3 and other oils derived from algae, utilizing advanced bioreactor systems. "By integrating photobioreactors with state-of-the-art fermentation technologies, we can ensure not only the sustainability but also the quality of our nutritional offerings," Bacchetta stated.

Conclusion

Zinzino’s acquisition of a significant share in Xion International Group represents a bold step toward further establishing itself as a leader in the health and wellness market. By focusing on sustainable production methods and innovative cultivation techniques, Zinzino is poised to meet the growing demand for high-quality omega-3 products while maintaining its commitment to environmental stewardship. With the launch of PhytoFerm on the horizon, Zinzino is set to redefine the future of nutritional solutions, making a meaningful impact on the industry and the consumers it serves.